vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Enphase Energy (ENPH). Click either name above to swap in a different company.
Enphase Energy is the larger business by last-quarter revenue ($282.9M vs $236.8M, roughly 1.2× CROSS COUNTRY HEALTHCARE INC). Enphase Energy runs the higher net margin — -2.6% vs -35.0%, a 32.4% gap on every dollar of revenue. On growth, Enphase Energy posted the faster year-over-year revenue change (-20.6% vs -23.6%). Enphase Energy produced more free cash flow last quarter ($83.0M vs $16.1M). Over the past eight quarters, Enphase Energy's revenue compounded faster (-3.4% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Enphase Energy, Inc. is an American energy technology company headquartered in Fremont, California, that develops and manufactures solar micro-inverters, battery energy storage, and EV charging stations primarily for residential customers. Enphase was established in 2006 and is the first company to successfully commercialize solar micro-inverters, which convert the direct current (DC) power generated by solar panels into grid-compatible alternating current (AC) for use or export.
CCRN vs ENPH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $282.9M |
| Net Profit | $-82.9M | $-7.4M |
| Gross Margin | — | 35.5% |
| Operating Margin | -30.2% | 54.0% |
| Net Margin | -35.0% | -2.6% |
| Revenue YoY | -23.6% | -20.6% |
| Net Profit YoY | -2109.7% | -124.9% |
| EPS (diluted) | $-2.56 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $282.9M | ||
| Q4 25 | $236.8M | $343.3M | ||
| Q3 25 | $250.1M | $410.4M | ||
| Q2 25 | $274.1M | $363.2M | ||
| Q1 25 | $293.4M | $356.1M | ||
| Q4 24 | $309.9M | $382.7M | ||
| Q3 24 | $315.1M | $380.9M | ||
| Q2 24 | $339.8M | $303.5M |
| Q1 26 | — | $-7.4M | ||
| Q4 25 | $-82.9M | $38.7M | ||
| Q3 25 | $-4.8M | $66.6M | ||
| Q2 25 | $-6.7M | $37.1M | ||
| Q1 25 | $-490.0K | $29.7M | ||
| Q4 24 | $-3.8M | $62.2M | ||
| Q3 24 | $2.6M | $45.8M | ||
| Q2 24 | $-16.1M | $10.8M |
| Q1 26 | — | 35.5% | ||
| Q4 25 | — | 44.3% | ||
| Q3 25 | 20.4% | 47.8% | ||
| Q2 25 | 20.4% | 46.9% | ||
| Q1 25 | 20.0% | 47.2% | ||
| Q4 24 | — | 51.8% | ||
| Q3 24 | 20.4% | 46.8% | ||
| Q2 24 | 20.8% | 45.2% |
| Q1 26 | — | 54.0% | ||
| Q4 25 | -30.2% | 6.5% | ||
| Q3 25 | -2.4% | 16.1% | ||
| Q2 25 | -2.1% | 10.2% | ||
| Q1 25 | -0.3% | 9.0% | ||
| Q4 24 | -1.1% | 14.3% | ||
| Q3 24 | 0.9% | 13.1% | ||
| Q2 24 | -5.7% | 0.6% |
| Q1 26 | — | -2.6% | ||
| Q4 25 | -35.0% | 11.3% | ||
| Q3 25 | -1.9% | 16.2% | ||
| Q2 25 | -2.4% | 10.2% | ||
| Q1 25 | -0.2% | 8.3% | ||
| Q4 24 | -1.2% | 16.2% | ||
| Q3 24 | 0.8% | 12.0% | ||
| Q2 24 | -4.7% | 3.6% |
| Q1 26 | — | $-0.06 | ||
| Q4 25 | $-2.56 | $0.29 | ||
| Q3 25 | $-0.15 | $0.50 | ||
| Q2 25 | $-0.20 | $0.28 | ||
| Q1 25 | $-0.02 | $0.22 | ||
| Q4 24 | $-0.13 | $0.46 | ||
| Q3 24 | $0.08 | $0.33 | ||
| Q2 24 | $-0.47 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $497.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $1.1B |
| Total Assets | $449.0M | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $497.5M | ||
| Q4 25 | $108.7M | $1.5B | ||
| Q3 25 | $99.1M | $1.5B | ||
| Q2 25 | $81.2M | $1.5B | ||
| Q1 25 | $80.7M | $1.5B | ||
| Q4 24 | $81.6M | $1.6B | ||
| Q3 24 | $64.0M | $1.8B | ||
| Q2 24 | $69.6M | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $322.8M | $1.1B | ||
| Q3 25 | $408.1M | $995.0M | ||
| Q2 25 | $412.2M | $880.6M | ||
| Q1 25 | $418.2M | $810.7M | ||
| Q4 24 | $419.0M | $833.0M | ||
| Q3 24 | $424.7M | $931.4M | ||
| Q2 24 | $433.3M | $884.5M |
| Q1 26 | — | $2.7B | ||
| Q4 25 | $449.0M | $3.5B | ||
| Q3 25 | $538.2M | $3.3B | ||
| Q2 25 | $553.8M | $3.2B | ||
| Q1 25 | $576.2M | $3.1B | ||
| Q4 24 | $589.3M | $3.2B | ||
| Q3 24 | $597.4M | $3.3B | ||
| Q2 24 | $602.9M | $3.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.11× | ||
| Q3 25 | — | 1.21× | ||
| Q2 25 | — | 1.37× | ||
| Q1 25 | — | 1.48× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 1.47× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $102.9M |
| Free Cash FlowOCF − Capex | $16.1M | $83.0M |
| FCF MarginFCF / Revenue | 6.8% | 29.3% |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $102.9M | ||
| Q4 25 | $18.2M | $47.6M | ||
| Q3 25 | $20.1M | $13.9M | ||
| Q2 25 | $4.2M | $26.6M | ||
| Q1 25 | $5.7M | $48.4M | ||
| Q4 24 | $24.2M | $167.3M | ||
| Q3 24 | $7.5M | $170.1M | ||
| Q2 24 | $82.4M | $127.1M |
| Q1 26 | — | $83.0M | ||
| Q4 25 | $16.1M | $37.8M | ||
| Q3 25 | $17.9M | $5.9M | ||
| Q2 25 | $2.3M | $18.4M | ||
| Q1 25 | $3.8M | $33.8M | ||
| Q4 24 | $21.7M | $159.2M | ||
| Q3 24 | $6.3M | $161.6M | ||
| Q2 24 | $79.6M | $117.4M |
| Q1 26 | — | 29.3% | ||
| Q4 25 | 6.8% | 11.0% | ||
| Q3 25 | 7.2% | 1.4% | ||
| Q2 25 | 0.8% | 5.1% | ||
| Q1 25 | 1.3% | 9.5% | ||
| Q4 24 | 7.0% | 41.6% | ||
| Q3 24 | 2.0% | 42.4% | ||
| Q2 24 | 23.4% | 38.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 2.8% | ||
| Q3 25 | 0.9% | 2.0% | ||
| Q2 25 | 0.7% | 2.3% | ||
| Q1 25 | 0.6% | 4.1% | ||
| Q4 24 | 0.8% | 2.1% | ||
| Q3 24 | 0.4% | 2.2% | ||
| Q2 24 | 0.8% | 3.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.23× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 2.69× | ||
| Q3 24 | 2.92× | 3.72× | ||
| Q2 24 | — | 11.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
ENPH
Segment breakdown not available.
